
Overview
Jennifer Amengual is an Oncologist practicing medicine in New York, New York.
Dr. Amengual is highly rated in 13 conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, T-Cell Lymphoma, Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), and Bone Marrow Aspiration.
Dr. Amengual is board certified in Internal Medicine and Medical Oncology. She is actively involved in clinical research, co-authoring 57 peer reviewed articles and participating in 9 clinical trials. Dr. Amengual is currently accepting new patients.
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- POS
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- PPO
- EPO
- HMO
- POS
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
161 Fort Washington Avenue, New York, NY 10032
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
8 Clinical Trials
CUIMC/Herbert Irving Pavilion
Barbara Pro is an Oncologist practicing medicine in New York, New York. Dr. Pro is highly rated in 18 conditions, according to our data. Her clinical expertise encompasses Peripheral T-Cell Lymphoma, T-Cell Lymphoma, Non-Hodgkin Lymphoma, Anaplastic Large Cell Lymphoma, and Bone Marrow Aspiration. Dr. Pro is currently accepting new patients.
CUIMC/Herbert Irving Pavilion
James McKiernan, MD, is the John K. Lattimer Professor of Urology and CEO of ColumbiaDoctors. He is also Senior Vice Dean for Clinical Affairs for Columbia University Vagelos College of Physicians and Surgeons. Dr. McKiernan graduated from Johns Hopkins University with a BA in biology and received his MD from Columbia University College of Physicians and Surgeons. He completed his training in urology and general surgery at NewYork-Presbyterian Hospital, followed by a urologic surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center. Dr. McKiernan's clinical practice is focused on urologic oncology and particularly on surgical therapy in high-risk patients with bladder and kidney cancers. Dr. McKiernan evaluates and treats over 1,000 patients with bladder cancer every year. His research, funded by NIH and biotechnology industry grants, focuses on developing novel therapeutics for bladder cancer treatment as well as comparative effectiveness research in urologic oncology. In the management of kidney and bladder cancer, he has special expertise in organ preservation and reconstructive surgery to maximize quality of life. Dr. McKiernan's research has been published in Cancer, Cancer Research, the Journal of Clinical Oncology, JAMA Oncology, Journal of Urology, Urologic Oncology, and Urology. He has authored and co-authored more than 220 scientific articles and book chapters on urologic cancer and related issues.For the past 10 years, he has directed a research team at Columbia University Medical Center investigating quality outcomes and effectiveness in urologic cancer surgery. He has served as the Vice Chairman for the AJCC TNM Staging Task Force, Co-Chair of the AUA Guidelines Panel on non-muscle invasive bladder cancer, as well as on the American Board of Urology and Society of Urologic Oncology Examination Committees. In addition, Dr. McKiernan is the principal investigator of the NIH-funded clinical trials program of experimental therapeutics in bladder cancer at Columbia University/NYPH, which is investigating new agents for bladder preservation in patients whose cancer has recurred after standard therapy. In collaboration with researchers at Columbia's Herbert Irving Comprehensive Cancer Center, his team continues to develop new therapeutic strategies for managing bladder cancer. Dr. Mckiernan is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Urothelial Cancer, Cystectomy, and Nephrectomy. Dr. Mckiernan is board certified in Urology. Dr. Mckiernan is currently accepting new patients.
CUIMC/Neurological Institute Of New York
Fabio Iwamoto is an Oncologist practicing medicine in New York, New York. Dr. Iwamoto is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, and Brain Tumor. Dr. Iwamoto is currently accepting new patients.
CUIMC/Herbert Irving Pavilion
Nicole Lamanna, MD, is an Associate Clinical Professor of Medicine in the Hematologic Malignancies Section of the Hematology/Oncology Division. Dr. Lamanna is a hematologist/oncologist whose research interests include lymphoid leukemias, specifically chronic lymphocytic leukemia. She is an experienced clinical investigator and her research focus has been the development of combination therapies that include chemoimmunotherapy, immunomodulatory drugs, novel kinase inhibitors and monoclonal antibodies. She also is working to find active, safer therapies for older patients with these diseases. She earned her medical degree from Albert Einstein College of Medicine and completed her fellowship in Hematology-Oncology at Memorial Sloan-Kettering Cancer Center. Dr. Lamanna is highly rated in 17 conditions, according to our data. Her clinical expertise encompasses Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Bone Marrow Aspiration, and Gastrostomy. Dr. Lamanna is board certified in Medical Oncology. Dr. Lamanna is currently accepting new patients.
CUIMC/Herbert Irving Pavilion
Dr. Hershman is Witten Family Professor of Medicine, American Cancer Society Professor of Medicine and Epidemiology, chief of the division of hematology/oncology, and deputy director of the Herbert Irving Comprehensive Cancer Center at Columbia University. She completed her medical degree at the Albert Einstein College of Medicine, and completed her internal medicine and oncology fellowship training at Columbia University Medical Center, where she served as Chief Resident. During that time she completed a Master's degree in Biostatistics at the Mailman School of Public Health. She has developed nationally recognized expertise in breast cancer treatment, prevention, and survivorship.Dr. Hershman has also developed a comprehensive multidisciplinary program to study ways of improving cancer care delivery (CCD), reducing disparities and designing studies to improve the quality of life and quality of care in breast cancer survivors. She has received funding from the American Society of Clinical Oncology, American Cancer Society, Department of Defense, Breast Cancer Research Foundation, PCORI, and the National Cancer Institute. She currently has mentored numerous faculty members who have been granted mentored career development awards, and has received the Women Who Conquer Cancer Mentorship Award and the CUIMC Mentor of the Year Award. Dr. Hershman has published over 450 scientific articles and has received several awards including the highly prestigious Advanced Clinical Research Award in Breast Cancer from the American Society of Clinical Oncology, the Advanced Medical Achievement Award from the Avon Foundation and a Giants in Cancer Care Award.She has several national leadership roles in oncology. As vice chair of the SWOG Cancer Research Network she oversees the NCI's Community Oncology Research Programs (NCORP) research portfolio, which includes prevention and epidemiology, cancer care delivery, symptom control and quality of life, and survivorship trials. Within ASCO she was selected to participate in the first Leadership Development Program and has been the Chair of the Grants Selection Committee, Chair of the ASCO Quality Care Symposium and has been a member of multiple committees and task-forces. She is on the editorial board for the Journal of Clinical Oncology and is an Associate Editor at the Journal of the National Cancer Institute. Dr. Hershman is highly rated in 18 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Febrile Neutropenia, Inflammatory Breast Cancer, Salpingo-Oophorectomy, and Hormone Replacement Therapy (HRT). Dr. Hershman is board certified in Internal Medicine and Medical Oncology. Dr. Hershman is currently accepting new patients.
The Ruttenberg Treatment Center
Matthew Galsky is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Galsky is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Orchiectomy, and Nephrectomy. Dr. Galsky is currently accepting new patients.
Frequently Asked Questions about Dr. Jennifer E. Amengual
How do I make an appointment with Dr. Jennifer E. Amengual?
You can book an appointment with Dr. Jennifer E. Amengual by calling their office at 212-305-0591. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Jennifer E. Amengual a top-rated expert for Non-Hodgkin Lymphoma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Jennifer E. Amengual is classified as an Elite expert for Non-Hodgkin Lymphoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Jennifer E. Amengual specialize in?
While Dr. Jennifer E. Amengual is a Oncology, they have specific expertise in Non-Hodgkin Lymphoma, T-Cell Lymphoma, and Hodgkin Lymphoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Jennifer E. Amengual participate in research or clinical trials?
Yes. Dr. Jennifer E. Amengual has published 57 articles and abstracts on conditions like Non-Hodgkin Lymphoma. You can view a list of Dr. Jennifer E. Amengual's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Jennifer E. Amengual accept my insurance?
Dr. Jennifer E. Amengual accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 212-305-0591 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Non-Hodgkin LymphomaDr. Amengual isElite. Learn about Non-Hodgkin Lymphoma.
- T-Cell LymphomaDr. Amengual isElite. Learn about T-Cell Lymphoma.
- Distinguished
- B-Cell LymphomaDr. Amengual isDistinguished. Learn about B-Cell Lymphoma.
- Diffuse Large B-Cell Lymphoma (DLBCL)Dr. Amengual isDistinguished. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
- Follicular LymphomaDr. Amengual isDistinguished. Learn about Follicular Lymphoma.
- Hodgkin LymphomaDr. Amengual isDistinguished. Learn about Hodgkin Lymphoma.
- Peripheral T-Cell LymphomaDr. Amengual isDistinguished. Learn about Peripheral T-Cell Lymphoma.
- Advanced
- Classical Hodgkin LymphomaDr. Amengual isAdvanced. Learn about Classical Hodgkin Lymphoma.
- Cutaneous T-Cell Lymphoma (CTCL)Dr. Amengual isAdvanced. Learn about Cutaneous T-Cell Lymphoma (CTCL).
- Gastric LymphomaDr. Amengual isAdvanced. Learn about Gastric Lymphoma.
- Large-Cell Immunoblastic LymphomaDr. Amengual isAdvanced. Learn about Large-Cell Immunoblastic Lymphoma.
- Mantle Cell Lymphoma (MCL)Dr. Amengual isAdvanced. Learn about Mantle Cell Lymphoma (MCL).
- Small Lymphocytic Lymphoma (SLL)Dr. Amengual isAdvanced. Learn about Small Lymphocytic Lymphoma (SLL).
- Experienced
- Acute Myeloblastic Leukemia with MaturationDr. Amengual isExperienced. Learn about Acute Myeloblastic Leukemia with Maturation.
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Amengual isExperienced. Learn about Acute Myeloid Leukemia (AML).
- AgranulocytosisDr. Amengual isExperienced. Learn about Agranulocytosis.
- Anaplastic Large Cell LymphomaDr. Amengual isExperienced. Learn about Anaplastic Large Cell Lymphoma.
- Angioimmunoblastic T-cell LymphomaDr. Amengual isExperienced. Learn about Angioimmunoblastic T-cell Lymphoma.
- Bone Marrow AspirationDr. Amengual isExperienced. Learn about Bone Marrow Aspiration.
- Burkitt LymphomaDr. Amengual isExperienced. Learn about Burkitt Lymphoma.
- Castleman DiseaseDr. Amengual isExperienced. Learn about Castleman Disease.
- Childhood Acute Myeloid LeukemiaDr. Amengual isExperienced. Learn about Childhood Acute Myeloid Leukemia.
- Chronic B-Cell Leukemia (CBCL)Dr. Amengual isExperienced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Dr. Amengual isExperienced. Learn about Chronic Lymphocytic Leukemia (CLL).
- Chronic T-Cell Leukemia (CTCL)Dr. Amengual isExperienced. Learn about Chronic T-Cell Leukemia (CTCL).
- Lymphofollicular HyperplasiaDr. Amengual isExperienced. Learn about Lymphofollicular Hyperplasia.
- Lymphoid HyperplasiaDr. Amengual isExperienced. Learn about Lymphoid Hyperplasia.
- Marginal Zone Lymphoma (MZL)Dr. Amengual isExperienced. Learn about Marginal Zone Lymphoma (MZL).
- Multicentric Castleman Disease (MCD)Dr. Amengual isExperienced. Learn about Multicentric Castleman Disease (MCD).
- Multiple MyelomaDr. Amengual isExperienced. Learn about Multiple Myeloma.
- Myelodysplastic Syndrome (MDS)Dr. Amengual isExperienced. Learn about Myelodysplastic Syndrome (MDS).
- Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
- Primary Lymphoma of the BrainDr. Amengual isExperienced. Learn about Primary Lymphoma of the Brain.
- Richter SyndromeDr. Amengual isExperienced. Learn about Richter Syndrome.
- Unicentric Castleman Disease (UCD)Dr. Amengual isExperienced. Learn about Unicentric Castleman Disease (UCD).


